AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out ...

Medicare bills are increasing for millions of Americans despite a $2,000 prescription drug cap beginning in 2025, as premiums ...

The Medicare Advantage Open Enrollment Period (Jan 1–Mar 31) lets you switch plans or adjust coverage. Review your options to ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...